Quality of life in refractory generalized myasthenia gravis: A rapid review of the literature
Author:
Affiliation:
1. Department of Evidence-Based Medicine, NeuroEconomix, Bogotá, Colombia.
2. Clinical Epidemiology and Biostatistics Department, Medical School, Pontificia Universidad Javeriana, Bogotá, Colombia.
Publisher
International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)
Subject
General Medicine
Link
https://www.jstage.jst.go.jp/article/irdr/8/4/8_2019.01121/_pdf
Reference32 articles.
1. 1. Gilhus NE. Myasthenia and the neuromuscular junction. Curr Opin Neurol. 2012; 25:523-529.
2. 2. Gilhus NE. Myasthenia Gravis. N Engl J Med. 2016; 375:2570-2581.
3. 3. Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol. 2010; 10:46.
4. 4. Silvestri NJ, Wolfe GI. Myasthenia gravis. Semin Neurol. 2012; 32:215-226.
5. 5. Luchanok V, Kaminski HJ. Natural History of Myasthenia Gravis. Engel A, ed. 2012; pp. 90-107.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Reimagining Myasthenia Gravis Care: Current Strategies and New Developments;EMJ Neurology;2024-08-13
2. Efficacy and Safety of Nipocalimab in Patients with Generalised Myasthenia Gravis: Top Line Results from the Double-Blind, Placebo-Controlled, Randomised Phase III Vivacity-MG3 Study;EMJ Neurology;2024-08-13
3. Expert consensus recommendations for improving and standardising the assessment of patients with generalised myasthenia gravis;European Journal of Neurology;2024-03-24
4. Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized study;Journal of Clinical Neuroscience;2024-01
5. Impact of Ravulizumab on Patient Outcomes and Quality of Life in Generalized Myasthenia Gravis;Patient Related Outcome Measures;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3